Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-31 @ 3:50 AM
Study NCT ID:
NCT07490002
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-24
First Post:
2026-02-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Therapy With Iparomlimab and Tuvonralimab, Lenvatinib and Chemotherapy in Resectable ESCC
Sponsor:
Changhai Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-04-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-11-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-02-05
First Submit QC Date:
None
Study First Post Date:
2026-03-24
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-19
Last Update Post Date:
2026-03-24
Last Update Post Date Type:
ACTUAL